Pulmonary immune response to Mycobacterium tuberculosis and human immunodeficiency virus

Infectious Agents and Disease

Volumn 5, Issue 2, 1996, Pages 108-118

  Rich, Elizabeth A ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 8; MACROPHAGE CHEMOTACTIC FACTOR; NEUTRALIZING ANTIBODY; PENTOXIFYLLINE; RANTES; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; BACTERIAL GROWTH; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IMMUNOREGULATION; LUNG ALVEOLUS CELL; LUNG ALVEOLUS MACROPHAGE; LUNG INFECTION; LUNG TUBERCULOSIS; MACROPHAGE ACTIVATION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; VIRUS REPLICATION;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; DNA, VIRAL; HIV; HIV CORE PROTEIN P24; HIV INFECTIONS; HUMANS; MACROPHAGES, ALVEOLAR; MICE; MONOCYTES; MYCOBACTERIUM TUBERCULOSIS; RABBITS; SMOKING; TRANSFORMING GROWTH FACTOR BETA; TUBERCULOSIS, PULMONARY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029874381     PISSN: 10562044     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Abbud RA, Alt SL, Rich EA. Phenotype of alveolar versus blood T lymphocytes in the acquired immunodeficiency syndrome and modulation of markers of activation by alveolar macrophages. Clin Res 1994;42:157A.
2. Abbud RA, Finegan CK, Guay LN, Rich EA. Enhanced production of human immunodeficiency virus-1 by in vitro infected alveolar macrophages from otherwise healthy smokers. J Infect Dis, 1995;172:859-63.
3. Agostini C, Zambello R, Trentin L, Garbisa S, DiCelle PF, Bulian P, Onisto M, Polelli V, Spiga L, Raise E, Foa R, Semenzato G. Alveolar macrophages from patients with AIDS and AIDS-related complex constitutively synthesize and release tumor necrosis factor alpha. Am Rev Respir Dix 1991;144:195-201.
4. Bermudez LE, Young LS, Enkel H. Interaction of My cobacterium avium complex with human macrophages: roles of membrane receptors and serum proteins. Infect Immun 1991;59:1697-702.
5. Blackwell JM, Exekowitz AB, Roberts MB, Channon JY, Sim RB, Gordon S. Macrophage complement and lectin-like receptors bind Leishmania in the absence of serum. J Exp Med 1985;162:324-31.
6. Boom WH, Wallis RS, Chervenak KA. Human M. tuberculosis-reactive CD4+ T-cell clones: heterogeneity in antigen recognition, cytokine production, and cytotoxicity for mononuclear phagocytes. Infect Immun 1991;59:2737-43.
7. Buhl R, Jaffe HA, Holroyd KJ, Borok Z, Roum JH, Mastrangeli A, Wells FB, Kirby M, Saltini C, Crystal RG. Activation of alveolar macrophages in asymptomatic HIV-infected individuals. J Immunol 1993;150:1019-28.
8. Bullock WE, Wright SD. Role of the adherence-promoting receptors, CR3, LFA-1, and p150,95, in binding of Histoplasma capsulatum by human macrophages. J Exp Med 1987;165:195-210.
9. Calvo CF, Bernard A, Huet S, Leroy E, Boumsell L, Senik A. Regulation of immunoglobulin synthesis by human T cell subsets as defined by anti-D44 monoclonal antibody within theCD4+ andCD8+ subpopulations. J Immunol 1986;136: 1144-6.
10. Clarke JR, Taylor IK, Fleming J, Nukuna A, Williamson JD, Mitchell DM. The epidemiology of HIV-1 infection of the lung in AIDS patients. AIDS 1993;7:555-60.
11. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM. Disseminated tuberculosis in interferongamma gene-disrupted mice. J Exp Med 1993;178:2243-47.
12. Crowle A, Dahl R, Ross E, May M. Evidence that vesicles containing living virulent M. tuberculosis or M. avium in cultured human macrophages are not acidic. Infect Immun 1991;59:1823-31.
13. Davidson BL, Faust J, Pessano S, Daniele RP, Rovera G. Differentiation and activation phenotypes of lung T-lymphocytes differ from those of circulating T lymphocytes. J Clin Invest 1985;76:60-5.
14. Denis M. Killing of Mycobacterium tuberculosis with human monocytes: activation by cytokines and calcitriol. Clin Exp Immunol 1991;84:200-6.
15. Downing J, Pasula R, Wright JR, Twigg III HL, Martin II WJ. Surfactant protein A promotes attachment of Mycobacterium tuberculosis to alveolar macrophages during HIV infection. Proc Natl Acad Sci USA 1995; in press.
16. Ellner JJ. Suppressor adherent cells in human tuberculosis. J Immunol 1978;121:2573-9.
17. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon γ in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993;178: 2249-54.
18. Folks T, Kelly J, Benn S, Kinter A, Justement J, Gold J, Redfield R, Sell KW, Fauci AS. Susceptibility of normal human lymphocytes to infection with HTLV-III/LAV. J Immunol 1986;136:4049-53.
19. Fujiwara H, Kleinhenz ME, Wallis RS, Ellner JJ. Increased interleukin-1 production and monocyte suppressor cell activity associated with human tuberculosis. Am Rev Respir Dis 1983;133:73-7.
20. Guillon J-M, Autran B, Denis M, Fouret P, Plata F, Maynaud CM, Akoun GM. Human immunodeficiency virus-related lymphocytic alveolitis. Chest 1988;94:1264-70.
21. Hirsch CS, Ellner JJ, Russell DG, Rich EA. Complement receptor 4-mediated uptake and tumor necrosis factor-mediated growth inhibition of Mycobacterium tuberculosis in human alveolar macrophages. J Immunol 1994;152:743-53.
22. Hirsch CS, Yoneda T, Averill L, Ellner JJ, Toossi Z. Enhancement of intracellular growth of Mycobacterium tuberculosis in human monocytes by transforming growth factor-β. J Infect Dis 1994;170:1229-37.
23. Horwitz MA. Phagocytosis of the legionnaires' disease bacterium (Legionella pneumophila) occurs by a novel mechanism: engulfment within a pseudopod coil. Cell 1984;36:27-33.
24. Kindler V, Sappino A-P, Grau GE, Piguet P-F, Vassalli P. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 1989;56:731-40.
25. Lederman MM, Georges DL, Kusner DJ, Giam C, Toossi Z. Mycobacterium tuberculosis and its purified protein derivative activate expression of the human immunodeficiency virus. J Acquir Immune Defic Syndr 1994;7:727-33.
26. Meltzer MS, Skillman DR, Hoover DL, et al. Macrophages and the human immunodeficiency virus. Immunol Today 1990;11:217-23.
27. Muller I, Cobbold S, Waldmann H, Kaufmann SME. Impaired resistance to M. tuberculosis after selective in vivo depletion of L3T4+ and Lyt-2+ T-cells. Infect Immun 1987;55:2037-41.
28. Mustafa AS, Godal T. BCG-induced CD4+ cytotoxic T-cells from BCG vaccinated healthy subjects: relation between cytotoxicity and suppression in vitro. Clin Exp Immunol 1987;69:255-62.
29. Myones BL, Dalzell JG, Hogg N, Ross GD. Neutrophil and monocytes cell surface p150,95 has iC3b-receptor (CR4) activity resembling CR3. J Clin Invest 1988;82:640-51.
30. Nieman RB, Fleming J, Coker RJ, Harris JRW, Mitchell DM. The effect of cigarette smoking on the development of AIDS in HIV-1 seropositive individuals. AIDS 1993;7:705-10.
31. Ogawa T, Uchida H, Hahada J. Increase in TNFα and IL-6 secreting cells in PBMC from subjects infected with M. tuberculosis. Infect Immun 1991;59:3021-5.
32. Orme IM. Characteristics and specificity of acquired immunologic memory to Mycobacterium tuberculosis infection. J Immunol 1988;140:3589-93.
33. Orme IM, Collins FM. Adoptive protection of the Mycobacterium tuberculosis infected lung: dissociation between cells that passively transfer protective immunity and those that transfer delayed-type hypersensitivity to tuberculin. Cell Immunol 1984;84:113-20.
34. Orme IM, Miller ES, Roberts AD, Furney SK, Griffin JP, Dobos EM, Chi D, Rivoire B, Brennan PJ. T-lymphocytes mediating protection and cellular cytolysis during the course of Mycobacterium tuberculosis. J Immunol 1992;148:189-96.
35. Payne NR, Horwitz MA. Phagocytosis of Legionella pneumophilia is mediated by human monocyte complement receptors. J Exp Med 1987;166:1377-89.
36. Plata F, Autran B, Martins LP, Wain-Hobson J, Raphael M, Mayaud C, Guillon M, Debre P. AIDS-virus specific cytoxic T lymphocytes in lung disorders. Nature 1987;328:348-51.
37. Rich EA, Chen ISY, Zack JA, Leonard ML, O'Brien WA. Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1). J Clin Invest 1992;89:176-83.
38. Rich EA, Cooper C, Toossi Z, Leonard ML, Stucky RM, Wiblin RT, Ellner JJ. Requirement for cell-to-cell contact for the immunosuppressive activity of human alveolar macrophages. Am J Respir Cell Mol Biol 1991;4:287-294.
39. Rich EA, Panuska JR, Wallis RS, Wolf CB, Ellner JJ. Dyscoordinate expression of tumor necrosis factor-alpha by human blood monocytes and alveolar macrophages. Am Rev Respir Dis 1989;139:1010-6.
40. Rich EA, Tweardy DJ, Fujiwara H, Ellner JJ. Spectrum of immunoregulatory functions and properties of human alveolar macrophages in health. Am Rev Respir Dis 1987;136: 258-65.
41. Rook GAW, Steele WJ, Ainsworth M, Champion BR. Activation of macrophages to inhibit proliferation of Mycobaclerium tuberculosis: comparison of the effects of recombinant gamma-interferon on human monocytes and murine peritoneal macrophages. Immunology 1986;59:333-8.
42. Sadek MI, Rich EA. Induction of chemotactic factors by infection of mononuclear phagocytes with Mycobacterium tuberculosis. Am J Respir Crit Care Med 1995;151:A123.
43. Salahuddin SZ, Rose RM, Groopman JE, Markham PD, Gallo RC. Human T lymphotropic virus type III infection of human alveolar macrophages. Blood 1986;68:281-4.
44. Schlesinger LS. Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J Immunol 1993;150:2920-30.
45. Schlesinger LS, Bellinger-Kawahara CG, Payne NR, Horwitz MA. Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. J Immunol 1990;144:2771-80.
46. Schlesinger LS, Horwitz MA. Phagocytosis of leprosy bacilli is mediated by complement receptors CR1 and CR3 on human monocytes and complement C3 in serum. J Clin Invest 1990;85:1304-14.
47. Schlesinger LS, Horwitz MA. Phagocytosis of Mycobacterium leprae by human monocyte-derived macrophages is mediated by complement receptors CR1 (CD35), CR3 (CD11b/CDl8), and CR4 (CD1 c/CD18) and IFN-γ activation inhibits complement receptor function and phagocytosis of this bacterium. J Immunol 1991;147:1983-94.
48. Schwander SK, Sada E, Torres M, Sierra JG, Alt SL, Rich EA. Compartmentalization of activated T lymphocytes in affected lungs during active pulmonary tuberculosis. Am J Respir Crit Care Med 1995;151:A246.
49. Sierra-Madero JG, Toossi Z, Hom DL, Finegan CK, Hoenig E, Rich EA. Relationship between load of virus in alveolar macrophages of human immunodeficiency virus-infected persons, production of cytokines and clinical status. J Infect Dis 1994;169:18-27.
50. Sturgill-Koszycki S, Schlesinger P, Charkroborty P, Haddix P, Collins H, Fok A, Allen R, Gluck S, Heuser J, Russel D. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesiculate proton-ATPase. Science 1994;163:678-81.
51. Takashima T, Keta C, Tsuyuguchi I, Kishimoto S. Production of tumor necrosis factor-α by monocytes from patients with pulmonary tuberculosis. Infect Immun 1990;58:3286-92.
52. Toossi Z, Gogate P, Shiratsuchi H, Young T, Ellner JJ. Enhanced production of TGF-β by blood monocytes from patients with active tuberculosis and presence of TGF-β in tuberculous granulomatous lung lesions. J Immunol 1995; 154:465-73.
53. Toossi Z, Sierra-Madero JG, Blinkhorn RA, Mettler MA, Rich EA. Enhanced susceptibility of blood monocytes from patients with pulmonary tuberculosis to productive infection with human immunodeficiency virus-1. J Exp Med 1993;177: 1511-6.
54. Trentin K, Barbisa S, Zambello R, Agostini C, Caenazzo C, di Francesco C, Cipriani A, Fracavalla, Semenzato G. Spontaneous production of IL-6 by alveolar macrophages from human immunodeficiency virus type-1 infected patients. J Infect Dis 1992;166:731-7.
55. Twigg HL, Iwamoto GK, Soliman DM. Role of cytokines in alveolar macrophage accessory cell function in HIV-infected individuals. J Immunol 1992;149:1462-9.
56. Twigg HL, Lipscomb MF, Yoffe B, Barbara DJ, Weissler JC. Enhanced accessory cell function of alveolar macrophages from patients with the human immunodeficiency virus: role for depletion of CD4 T cells in the lung. Am J Respir Cell Mol Biol 1989;1:391-400.
57. Valone SE, Rich EA, Wallis RS, Ellner JJ. Expression of tumor necrosis factor in vitro by human mononuclear phagocytes stimulated with whole Mycobacterium bovis BCG and mycobacterial antigens. Infect Immun 1988;56:3313-5.
58. Wallis RS,Vjecha M, Amir-Tahmasseb M, Okwera A, Byek-waso F, Nyole J, Kabengera J, Mugerwa RD, Ellner JJ. Influence of tuberculosis on HIV: enhanced cytokine expression and elevated β2 microglobulin in HIV-1 associated tuberculosis. J Infect Dis 1992;167:43-48.
59. Whalen C. Horsburgh CR, Hom D, Lahart C, Simberkoff M, Ellner JJ. Accelerated course of human immunodeficiency virus infection after tuberculosis. Am J Respir Crit Care Med 1995;151:129-135.
60. Wilson ME, and Pearson RD. Roles of CR3 and mannose receptors in the attachment and ingestion of Leichmania donovani by human mononuclear phagocytes by human mononuclear phagocytes. Infect Immun 1988;56:363-369.
61. Zack JA, Arrigo SJ, Weitsman SR, Go AS, Haislip A, Chen ISY. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 1990;61:213-22.